New White Paper - Read AAM Report on Drug Shortages
  • FDA Commissioner Dr. Robert Califf
    FDA Commissioner Dr. Robert Califf at GRx+Biosims 2023
    We’re thrilled to announce that Dr. Robert Califf will be our keynote FDA speaker, joining us in-person for a special “Fireside Chat.” Don’t miss this opportunity to hear from top industry professionals and thought leaders!
  • GRx+Biosims 2023
    Join Us at GRx+Biosims 2023
    GRx+Biosims 2023 is the premier scientific & regulatory and policy event for the U.S. generics and biosimilars industry, featuring timely programming relevant to technical, regulatory and policy professionals. Top officials and subject-matter experts share their knowledge and best practices to enhance attendees' understanding of how to succeed in generic and biosimilar development, regulatory process and approvals, and the evolving policy landscape.
  • Fireside chat with Mark Cuban at Access! 2023
    Fireside Chat with Mark Cuban
    Entrepreneur and founder of the Mark Cuban Cost Plus Drug Company, PBC, Mark Cuban, sat down with our new Board Chair Christine Baeder, SVP, COO for US Generics at Teva Pharmaceuticals, to discuss his efforts to reduce #drugprices and increase competition in the drug market.
  • Access! 2023 - AAM Annual Meeting
    ICYMI: See What Happened at Access! 2023
    Follow updates on social media with hashtag #Access2023.

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.